EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mustang Bio's enterprise value is $-0.48 Mil.
Mustang Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Mustang Bio's EV-to-Revenue for today is .
The historical rank and industry rank for Mustang Bio's EV-to-Revenue or its related term are showing as below:
During the past 9 years, the highest EV-to-Revenue of Mustang Bio was 1135.40. The lowest was -2965.36. And the median was -824.72.
MBIO's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.95 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-05-14), Mustang Bio's stock price is $0.2686.
Mustang Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, Mustang Bio's PS Ratio for today is .
Mustang Bio EV-to-Revenue Historical Data
The historical data trend for Mustang Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mustang Bio's EV-to-Revenue
For the Biotechnology subindustry, Mustang Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mustang Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Mustang Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Mustang Bio's EV-to-Revenue falls into.
Mustang Bio's current Enterprise Value is $-0.48 Mil.
Mustang Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mustang Bio's share price for today is $0.2686.
Mustang Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mustang Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Mustang Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MBIO has been successfully added to your 